Eligibility for statin therapy according to new cholesterol guidelines and prevalent use of medication to lower lipid levels in an older US Cohort: the Atherosclerosis Risk in Communities Study Cohort.
Minneapolis Heart Institute, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota.
Michael D
MD
Miedema
Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis.
Faye L
FL
Lopez
Ciccarone Center for the Prevention of Heart Disease, Johns Hopkins School of Medicine, Baltimore, Maryland.
Michael J
MJ
Blaha
Center for Innovations, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas.
Salim S
SS
Virani
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Josef
J
Coresh
Section of Cardiovascular Research, Department of Medicine, Baylor College of Medicine, Houston, Texas7Houston Methodist DeBakey Heart and Vascular Center, Houston, Texas.
Christie M
CM
Ballantyne
Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis.
Aaron R
AR
Folsom
D000368:Aged; D000369:Aged, 80 and over; D050197:Atherosclerosis / Q000188:drug therapy / Q000517:prevention & control*; D015331:Cohort Studies; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D008055:Lipids / Q000097:blood*; D008297:Male; D017410:Practice Guidelines as Topic; D014481:United States
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008055:Lipids